000 01590 a2200457 4500
005 20250516203737.0
264 0 _c20141121
008 201411s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdu029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChand, M
245 0 0 _aEMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cApr 2014
300 _a858-863 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aNeoplasm Staging
650 0 4 _aPreoperative Period
650 0 4 _aPrognosis
650 0 4 _aProportional Hazards Models
650 0 4 _aRectal Neoplasms
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aBhangu, A
700 1 _aWotherspoon, A
700 1 _aStamp, G W H
700 1 _aSwift, R I
700 1 _aChau, I
700 1 _aTekkis, P P
700 1 _aBrown, G
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 25
_gno. 4
_gp. 858-863
856 4 0 _uhttps://doi.org/10.1093/annonc/mdu029
_zAvailable from publisher's website
999 _c23675606
_d23675606